Medivizor

Title of notification

Here comes the notification
X
 
icon
prostate cancer | Medivizor | source: Medivizor | Added Aug 08, 2021

Positive Thinking and Cancer-Myth-Making

Called the "Emperor of All Maladies." there's little doubt that a cancer diagnosis throws life completely out of control.  Unfortunately, this chaos creates vulnerabilities that can and have been exploited.  It is tempting to believe the idea that if you control your thoughts and make them positive, you can control
icon
prostate cancer | Medivizor | source: Medivizor | Added Aug 06, 2021

Oncology Basics 2016: Genes and Cancer Treatment

In Oncology Basics 2016 part 1, we examined the elegance of the cells that make up our body.  In Oncology Basics 2016 part 2, we explored what holds the instructions for life--DNA--and the special processes of self-replication and transcription that are used to pass on and translate those instructions.  Now
icon
prostate cancer | Medivizor | source: Medivizor | Added Aug 04, 2021

Oncology Basics 2016: The Immune System and Immunotherapy

Oncology Basics 2016 continues with a look at the immune system and immunotherapy.  As described in a previous post, one of the regulators of cell division and proliferation is the immune system.  Harnessing the power of the immune system to attack and destroy cancer cells is a promising area of
icon
prostate cancer | Medivizor | source: Medivizor | Added Jul 30, 2021

15 Tips to Cope with Scanxiety (Scan Anxiety)

"Keep Calm And Carry On:" Really? “The shock of that day you hear the words, ‘you have cancer’ never leaves you and your sense of certainty in life and in your body can be hard to recapture after a diagnosis of cancer.”-Marie Ennis-O'Connor After Surgery, Chemo, Radiation This is the
icon
prostate cancer | Medivizor | source: Medivizor | Added Jul 26, 2021

Cancer Patient Resources: Free Air Travel

Cost Medical care for cancer is costly. In addition, there is the financial burden that patients and families face in getting to and from the best care--which may be located at medical centers far from home. The situation can seem overwhelming. Corporate Angel Network Into this dilemma, little known resources
icon
icon
prostate cancer | Research | Treatment | 10 pages | source: International journal of radiation oncology, biology, physics | Added Jul 24, 2021

Evaluating hypofractionated radiotherapy after prostate surgery in patients with prostate cancer.

This study investigated the outcomes of hypofractionated intensity-modulated radiation therapy (H-IMRT) to the prostate bed in patients with localized prostate cancer after prostate surgery. The data showed that H-IMRT after prostate surgery was safe and well-tolerated in these patients.

icon
icon
prostate cancer | Research | Treatment | 10 pages | source: Journal of Urology | Added Jul 20, 2021

Comparing darolutamide with apalutamide and enzalutamide for treating non-metastatic castration-resistant prostate cancer.

The study compared the effectiveness and safety outcomes of darolutamide (Nubeqa) with apalutamide (Erleada) and enzalutamide (Xtandi) in treating non-metastatic castration-resistant prostate cancer (CRPC). The data showed that darolutamide was safer and had similar effectiveness compared to apalutamide and enzalutamide.

icon
icon
prostate cancer | Research | Treatment | 10 pages | source: Frontiers in oncology | Added Jul 17, 2021

Comparing docetaxel to abiraterone in patients with metastatic castration-sensitive prostate cancer

This study compared the effectiveness of docetaxel (DOC; Taxotere) to abiraterone (ABI; Zytiga) and assessed possible predictive markers of progression-free survival (PFS) in patients with metastatic castration-sensitive prostate cancer (mCSPC). The authors concluded that under real-world conditions, ABI was associated with better PFS in these patients.

icon
prostate cancer | Research | 10 pages | source: Cancer | Added Jul 15, 2021

Does androgen-deprivation therapy increase risk of mortality from heart attack or stroke?

This study examined the risk of heart-related mortality in patients undergoing androgen-deprivation therapy (ADT) for prostate cancer. It found that patients treated with radiation therapy and ADT did not have an increased risk of heart-related mortality.

icon
icon
prostate cancer | Research | Treatment | 10 pages | source: PLOS ONE | Added Jul 12, 2021

Evaluating the association between the lowest PSA value after prostate surgery and the occurrence of biochemical recurrence in patients with localized prostate cancer

This study investigated the association between the lowest PSA value after radical prostatectomy (RP; surgery to remove the prostate) and the occurrence of biochemical recurrence (BCR) in patients with localized prostate cancer (PCa). The study found that a higher PSA value after RP and a shorter time to reach this value could predict the risk of BCR in these patients.

View

Category

  • icon
  • icon
  • icon
  • icon
  • icon
  • icon
  • icon
  • icon
  • icon

Was this helpful?